Search results
Results from the WOW.Com Content Network
Organon (OGN) delivered earnings and revenue surprises of 17.86% and 2.94%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Organon expects net leverage to be elevated above 4.0x due to the transaction. Price Action: At last check on Wednesday, OGN stock was down 2.14% at $20.11, while ROIV stock was down 0.08%. Read Next:
Stock indexes closed mostly lower Tuesday as the market delivered a downbeat finish on the final day of another milestone-shattering year on Wall Street. The Dow Jones Industrial Average slipped 0 ...
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. [4] Organon specializes in the following core therapeutic fields: reproductive medicine , contraception , psychiatry , hormone replacement therapy (HRT), and anesthesia .
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
The S&P 500 is a stock market index maintained by S&P Dow Jones Indices. It comprises 503 common stocks which are issued by 500 large-cap companies traded on the American stock exchanges (including the 30 companies that compose the Dow Jones Industrial Average). The index includes about 80 percent of the American market by capitalization.
The company posted quarterly revenue of $1.61 billion, beating analysts' average estimate of $1.57 billion. "In the United States, the Dobbs decision has driven an increase in demand from patients ...
For premium support please call: 800-290-4726 more ways to reach us